Topic
2026 Global Market Outlook: Tier 1 Buy-Side Research Reports
The 2026 global market outlook is defined by a resilient equity rally led by an 'AI meltup' that has broadened from hardware and semiconductors into enterprise software firms. Despite U.S. PCE inflation reaching 3.8%, markets remain optimistic, with the S&P 500 achieving its ninth consecutive weekly gain amid high-conviction growth opportunities in the technology and industrial sectors. Geopolitical instability remains a critical factor, specifically the disruption of 10.5mb/d of oil production due to the Strait of Hormuz closure, though recent ceasefire rumors have helped moderate energy prices and tighten credit spreads. Tactical opportunities are emerging in regional markets like Colombia, where fiscal reform agendas are driving asset rallies, and in Asian technology themes. To manage this environment of high refinery margins and persistent inflation, research advocates for a core-satellite portfolio structure with a 20-40% allocation to alternatives. This diversified approach aims to balance the high growth of the AI infrastructure cycle against the supply deficits currently straining global energy inventories.
6390 reports available
All reports
Page 112 of 267
USDZAR Near-term Volatility Medium-term ZAR Upside
UBS · Jun 9, 2026
Looking Under the ETF Hood
Convexity Maven · Jun 9, 2026
Americas Technology Real Estate Tech Existing Home Sales Update
Goldman Sachs · Jun 9, 2026
Cutting Through The Noise
BlackRock · Jun 9, 2026
GS Morning Market Update
Goldman Sachs · Jun 9, 2026
Lyell Immunopharma Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 9, 2026
The Kevin Warsh Fed
TS Lombard · Jun 9, 2026
Navigating China Internet and AI Models
Goldman Sachs · Jun 9, 2026
US Oil Rig Count Trends
Barclays · Jun 9, 2026
ECB Preview: Heading for a Policy Mistake
Berenberg · Jun 9, 2026
Markets Today
Bank of New Zealand · Jun 9, 2026
Research Unplugged: Data Centers and Behind the Meter Solutions
Goldman Sachs · Jun 9, 2026
Up And Adam
Raymond James · Jun 9, 2026
Oric Pharmaceuticals Inc. Key Takeaways
Goldman Sachs · Jun 9, 2026
AI’s Next Phase From Capital Spending To Capital Returns
Nuveen · Jun 9, 2026
Recombinant DNA: 250 Years of US Innovation
UBS Financial Services Inc. · Jun 9, 2026
Shoring Up The Indian Rupee – RBI June 2026 Measures
MUFG · Jun 9, 2026
Kiniksa Pharmaceuticals Key Takeaways
Goldman Sachs · Jun 9, 2026
Europe First to Market
J.P. Morgan · Jun 9, 2026
GS Utilities Daily
Goldman Sachs · Jun 9, 2026
Will the IPO Wave Derail Equities
Deutsche Bank · Jun 9, 2026
BoJ Monetary Policy Meeting Preview
Citi · Jun 9, 2026
Daily FX Update
Scotiabank · Jun 9, 2026
Daily Points
Scotiabank · Jun 9, 2026